Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents?

Drugs. 1971;1(2):109-15. doi: 10.2165/00003495-197101020-00001.
No abstract available

Publication types

  • Review

MeSH terms

  • Administration, Oral
  • Adolescent
  • Adult
  • Blood Glucose / metabolism
  • Carbohydrates / adverse effects
  • Child
  • Coronary Disease / complications
  • Coronary Disease / etiology
  • Diabetes Complications
  • Diabetes Mellitus / drug therapy
  • Diet, Diabetic
  • Fatty Acids / blood
  • Glyburide / therapeutic use
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Insulin / blood
  • Insulin / metabolism
  • Insulin Secretion
  • Islets of Langerhans / metabolism
  • Sulfonylurea Compounds / administration & dosage
  • Sulfonylurea Compounds / adverse effects
  • Sulfonylurea Compounds / metabolism
  • Sulfonylurea Compounds / pharmacology
  • Sulfonylurea Compounds / therapeutic use*
  • Sulfonylurea Compounds / toxicity
  • Tolbutamide / adverse effects
  • Tolbutamide / pharmacology
  • Tolbutamide / toxicity

Substances

  • Blood Glucose
  • Carbohydrates
  • Fatty Acids
  • Hypoglycemic Agents
  • Insulin
  • Sulfonylurea Compounds
  • Tolbutamide
  • Glyburide